Trial intelligence / Profile preview

Methoxyflurane for pain relief during outpatient hysteroscopy

ACTRN12620000216910Phase 4Not yet recruiting

Sponsor
Waikato District Health Board
Start
Apr 2020
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of methoxyflurane and Normal Saline-Benha University in menstrual disorders (2 arms), sponsored by Waikato District Health Board. Primary endpoint: Pain score during procedure. Planned start Apr 2020; status: not yet recruiting.

02

Drugs

methoxyfluraneNormal Saline-Benha University
03

Conditions

menstrual disorders

Beyond the preview

Go deeper on ACTRN12620000216910.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12620000216910.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call